-
Mashup Score: 4Expopoint - 2 hour(s) ago
MILANO – IRCCS Ospedale San Raffaele, Venerdì 13 Dicembre 2024 Nell’ ultimo decennio, l’ oncologia urologica ha conosciuto uno sviluppo significativo dell’ attivit à multidisciplinare, con urologi, oncologi, radioterapisti e medici nucleari coinvolti nel trattamento sempre pi ù complesso dei tumori urogenitali. Le innovazioni nelle tecniche chirurgiche e radioterapiche e l’ aumento del numero di farmaci oggi disponibili rendono necessario un aggiornamento continuo dei percorsi diagnostici e terapeutici
Source: www.expopoint.itCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
Breast cancer is one of the most common malignancies diagnosed in older adults [1]. Older adults often will live several years with metastatic breast cancer and face age-related health concerns such as frailty and functional decline in addition to symptoms related to their cancer and treatments.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0El Hospital Mancha Centro, reconocido como Unidad de Excelencia en Síndrome Hemolítico Urémico Atípico - 3 hour(s) ago
Se trata de una unidad multidisciplinar formada por los servicios de Nefrología, Hematología, Farmacia Hospitalaria y Análisis Clínicos para tratar una patología muy grave y compleja que afecta al riñón
Source: www.abc.esCategories: General Medicine News, Hem/OncsTweet-
https://t.co/lvGjNv7Lkg El Hospital Mancha Centro, reconocido como Unidad de Excelencia en SHUa, destaca la importancia del manejo multidisciplinar en Hematología, Nefrología, Farmacia y Análisis clínicos, para esta rara enfermedad. Detección precoz y terapias dirigidas salvan… https://t.co/JpISYePHFI
-
-
Mashup Score: 6Recommendations on prevention of infections during chimeric antigen receptor T‐cell and bispecific antibody therapy in multiple myeloma - 3 hour(s) ago
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma - 3 hour(s) ago
Bispecific antibodies (BsAbs) create an immunologic synapse between T cells and malignant cells, via T-cell surface marker CD3 and a tumor cell surface marker, activating T cells to achieve tumor cell killing. B-cell maturation antigen (BCMA) × CD3-directed BsAbs show promising activity against multiple myeloma (Table 1). 1 Teclistamab is the first BCMA-BsAb approved by the European Medicines Agency and US Food and Drug Administration for relapsed/refractory multiple myeloma (RRMM). 2. Rates of Infection
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients - 3 hour(s) ago
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and pneumococcal vaccination in the prior 5 years impacted overall survival versus no vaccination. Additionally, deaths due to infections were lower among vaccinated versus non-vaccinated patients. Vaccination status should be recorded in prospective clinical trials as it may affect survival.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0GLOBAL RATES OF INFLUENZA (FV) AND PNEUMOCOCCAL (PV) VACCINATION IN... by Dr. Michael A. Thompson - 3 hour(s) ago
EHA Library; A. Thompson M. Jun 12 2020; 294884;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Program Guide – ASCO Meeting Program Guide - 3 hour(s) ago
Michael A. Thompson Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI Michael A. Thompson, Jenny Ahlstrom, Nathan W. Sweeney Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI, CrowdCare Foundation, Draper, UT, HealthTree, Lehi, UT Takeda, Sanofi and GSK for HealthTree Background: Multiple myeloma (MM) is a cancer of the immune system. Infection is a major cause of morbidity and mortality in MM. Vaccines are the first line of prevention
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 3 hour(s) ago
Michael A. Thompson Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI Michael A. Thompson , Caitlin Costello , Jesus G. Berdeja , Faith Davies , Jeffrey A. Zonder , Hans Chulhee Lee , Jim Omel , Andrew Spencer , Evangelos Terpos , Vania Hungria , Noemi Puig , Cheng-Cheng Fu , Tomas Skacel , Renda H. Ferrari , Kaili Ren , Dawn Marie Stull , Ajai Chari Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI, Department of Medicine, Division of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Listeria Susceptibility in Patients With Multiple Myeloma Receiving Daratumumab-Based Therapy - 4 hour(s) ago
This case-control study examines the association of Listeria monocytogenes susceptibility with the receipt of daratumamab-based therapy in Canadian patients with multiple myeloma.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
One month left #GURetreat24 https://t.co/7wLIEJ83kF @SanRaffaeleMI @MyUniSR @GTumors @IBCG_BladderCA @UroDocAsh @PGrivasMDPhD @SpiessPhilippe @shilpaonc @y_loriot @montypal @neerajaiims @NazliDizman @Albert0Briganti @_alelarcher @BrigidaMaiorano @CMercinelli @vale_tateo… https://t.co/2RnRxE20N7 https://t.co/YtEK0iO1hr